|
61
|
222
|
5l5yL |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
68
|
250
|
5l5wA |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
57
|
204
|
5l5wI |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
62
|
220
|
5lezH |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
63
|
241
|
5l66G |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
58
|
226
|
5l69H |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
71
|
243
|
5l5vF |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
57
|
204
|
5l5uI |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
64
|
237
|
5lexC |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
65
|
230
|
5lf7A |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
61
|
231
|
5l5xE |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
152
|
399
|
5lmcA |
Oxidized flavodiiron core of escherichia coli flavorubredoxin, including the fe-4sg atoms from its rubredoxin domain |
|
61
|
231
|
5l64E |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
63
|
241
|
5l5zG |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
62
|
231
|
5l60E |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
200
|
5leyK |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
54
|
196
|
5lf3J |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
70
|
243
|
5l62F |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
62
|
220
|
5le5H |
Native human 20s proteasome at 1.8 angstrom |
|
68
|
213
|
5lf4L |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
69
|
244
|
5l64B |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
59
|
196
|
5l5wN |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
69
|
243
|
5l60F |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
70
|
243
|
5l67F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
68
|
242
|
5l6aD |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
58
|
204
|
5l61I |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
57
|
202
|
5lexN |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
69
|
243
|
5l66F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
67
|
230
|
5lf4A |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
69
|
233
|
5lttM |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
68
|
242
|
5l5wD |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
61
|
230
|
5lexA |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
61
|
231
|
5l63E |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
59
|
196
|
5l5iN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
74
|
248
|
5lf1B |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
58
|
204
|
5l69I |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
63
|
222
|
5l6aL |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
58
|
226
|
5l5pH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
58
|
222
|
5l65L |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
65
|
250
|
5l60A |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
68
|
233
|
5l62M |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
66
|
237
|
5lf4C |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
66
|
240
|
5l5oC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
71
|
244
|
5lttB |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
63
|
241
|
5l6bG |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
59
|
196
|
5l5uN |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
57
|
226
|
5l5tH |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
68
|
240
|
5l63C |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
65
|
250
|
5l61A |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
57
|
202
|
5lf4N |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
